亚历克西斯实用战术 LEXI 深 沪
等待开盘 05-18 09:30:00 美东时间
39.235
-0.420
-1.06%
华盛通- 最 高39.305
- 今 开39.25
- 成交量 1.51万股
- 最 低 39.21
- 昨 收 39.655
- 总市值 1.73亿
- 52周最高 39.67
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 30.614
- 委 比 -89.47%
- 总股本 441.68万
- 历史最高 39.67
- 量 比 1.83
- 振 幅 0.24%
- 历史最低 19.647
- 每 手 1
- 风险率 2.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-BofA Revises Down 2026 European Natural Gas Forecasts to 55 euros/MWh
BRIEF-BofA Revises Down 2026 European Natural Gas Forecasts to 55 euros/MWh May 13 (Reuters) - BANK OF AMERICA CORP BAC.N : SAYS WITH EUROPEAN NATURAL GAS STOCKS AT VERY LOW LEVELS BUT MORE FLEXIBLE EU GOVERNMENT FILL MANDATE, EU TTF PRICES HAVE UNDERPERFORMED OIL ADJUSTS EU TTF NATURAL GAS FORECAST
05-13 21:25
港股早知道 | 中美将在韩国举行经贸磋商！传DeepSeek计划融资500亿元
中美将在韩国举行经贸磋商！传DeepSeek计划融资500亿元，估值达515亿美元；乐动机器人今日上市，公开发售超购逾6700倍>>
05-11 08:02
BRIEF-Saudi Aramco Q1 Cash Flow From Operating Activities $30.7 Billion
BRIEF-Saudi Aramco Q1 Cash Flow From Operating Activities $30.7 Billion May 10 (Reuters) - SAUDI ARABIAN OIL CO 2222.SE : SAUDI ARAMCO - Q1 CASH FLOW FROM OPERATING ACTIVITIES: $30.7 BILLION SAUDI ARAMCO - Q1 FREE CASH FLOW: $18.6 BILLION SAUDI ARAMCO - Q1 FREE CASH FLOW: $18.6 BILLION, IMPACTED BY
05-10 13:06
Voyager Therapeutics To Present Eight Oral And Poster Studies At ASGCT 2026, Including Late‑Breaking GLP Toxicology Data On Investigational Tau‑Silencing Alzheimer's Gene Therapy VY1706 Ahead Of Planned IND Filing In Q2 And First‑In‑Human Dosing In H2 2026
- Late-breaking oral presentation: IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month GLP toxicology study in NHPs -- Additional data demonstrate
04-28 04:37
LNG tanker orders gain pace despite mixed outlook from Iran war
LNG tanker orders gain pace despite mixed outlook from Iran war More LNG supply from US, elsewhere boosts need for LNG carriers 35 LNGC orders in Q1 2026 vs 37 in 2025, consultancies say Market uncertainty could delay some new build orders - analyst By Emily Chow SINGAPORE, April 27 (Reuters) - Glob
04-27 15:27
Flexible Solutions See Q1 Revenue Of $8.3M Up ~11% From $7.5M YoY
FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability
04-21 21:07
BRIEF-Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington
BRIEF-Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington April 13 (Reuters) - Piramal Pharma Ltd PIRM.NS : CLOSURE OF US FDA INSPECTION AT MANUFACTURING FACILITY AT LEXINGTON US FDA HAS ISSUED EIR FOR SAID MANUFACTURING FACILITY WITH VAI Source text: ID:nBSEbbHpn
04-13 12:52
FLEXIBLE SOLUTIONS Announces Delay In Releasing Its Full Year 2025 Financials
FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient
04-01 04:41
BRIEF-FDA Aware Of Erbe USA Asking Removal Of Certain Flexible Cryoprobes From Customers
BRIEF-FDA Aware Of Erbe USA Asking Removal Of Certain Flexible Cryoprobes From Customers March 25 (Reuters) - FDA: FDA: AWARE THAT ERBE USA HAS ISSUED LETTER TO AFFECTED CUSTOMERS RECOMMENDING CERTAIN ERBE FLEXIBLE CRYPROBES BE REMOVED - WEBSITE FDA: AS OF FEBRUARY 24, ERBE USA HAS REPORTED 5 SERIOU
03-25 22:57
BRIEF-Nov Inc Announces $200 Million Capital Expansion For Offshore And High-Co₂ Solutions
BRIEF-Nov Inc Announces $200 Million Capital Expansion For Offshore And High-Co₂ Solutions March 25 (Reuters) - Nov Inc NOV.N : NOV INC - PLANS TO ROUGHLY DOUBLE CAPACITY OF ITS SUBSEA FLEXIBLE PIPE MANUFACTURING FACILITY IN AÇU, BRAZIL OVER NEXT THREE YEARS (ADDS DROPPED SOURCE) NOV INC - ANNOUNCES
03-25 18:38
